[ABT] Abbott Laboratories


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 38.41 Change: 0.12 (0.31%)
Ext. hours: Change: 0 (0%)

chart ABT

Refresh chart

Strongest Trends Summary For ABT

ABT is in the long-term up 200% above S&P in 24 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company?s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification,

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS0.94 EPS Growth - 4 Quarters1349.62% EPS Growth - Q/Q238.84%
EPS Growth - Y/Y-44.39% Sales Growth - 4 Quarters -18.92% Sales Growth - Q/Q-7.43% P/E51.29
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA9.75% ROE19.21% ROI12.44%
Current Ratio2.17 Quick Ratio1.89 Long Term Debt/Equity0.55 Debt Ratio0.42
Gross Margin55.74% Operating Margin13.95% Net Profit Margin20.6% Dividend Payout Ratio-32.44%
Dividend Yield
Fundamental Data
Cash From Financing Activities-550 M Cash From Investing Activities-205 M Cash From Operating Activities2 M Gross Profit2.95 B
Net Profit784 M Operating Profit729 M Total Assets43.1 B Total Current Assets19.99 B
Total Current Liabilities9.21 B Total Debt8.46 B Total Liabilities21.22 B Total Revenue5.17 B
Technical Data
High 52 week79.73 Low 52 week53.74 Last close75.97 Last change-0.82%
RSI36.28 Average true range1.51 Beta0.56 Volume3.81 M
Simple moving average 20 days-1.58% Simple moving average 50 days-2.29% Simple moving average 200 days14.05%
Performance Data
Performance Week-0.63% Performance Month4.24% Performance Quart1.37% Performance Half29.53%
Performance Year36.11% Performance Year-to-date22.22% Volatility daily1.12% Volatility weekly2.5%
Volatility monthly5.12% Volatility yearly17.75% Relative Volume228.71% Average Volume5.53 M
New High New Low


2019-11-12 06:24:09 | Abbott Ireland Financing DAC -- Moody's assigns A3 ratings to Abbott's unsecured euro note offering

2019-11-08 10:38:09 | Abbott Is One Of The Biggest Medical Stocks — Should You Buy ABT Stock Now?

2019-11-07 16:39:27 | IBD Stock Of The Day Breaks Out To Record High After Crushing Earnings Views

2019-11-07 09:39:00 | The Bond Market’s BBB Team Is Losing Members. Here’s Why That Matters.

2019-11-06 09:42:02 | Medical Products' Nov 7 Earnings Roster: ABC, CAH & More

2019-11-06 08:37:00 | Abbott Announces Discovery of New Strain of HIV, Keeping Global Health Community a Step Ahead of the Virus

2019-11-06 05:15:15 | Abbott Laboratories NYSE:ABT Seems To Use Debt Rather Sparingly

2019-11-04 14:14:52 | UPDATE 2-FDA classifies Abbott's blood pumping system recall as most serious

2019-11-04 09:37:02 | 3 Medical Product Stocks Likely to Beat This Earnings Season

2019-10-30 12:44:29 | Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More

2019-10-29 17:01:09 | McDonald's, AbbVie nab 2019 Chicago Innovation Awards

2019-10-29 09:59:01 | Medical Products' Oct 30 Earnings Roster: MCK, MASI & More

2019-10-24 10:59:00 | Abbott Labs Has Concocted a Way to Advance Further

2019-10-23 09:20:01 | Medical Products' Oct 24 Earnings Roster: BAX, CERN & More

2019-10-23 07:40:11 | Here's Why You Should Hold on to Abbott ABT Stock for Now

2019-10-22 19:04:53 | Beating the Street: The Art, Science and Legwork of Investing

2019-10-22 11:25:03 | Medical Products' Earnings Roster for Oct 23: TMO, BSX & More

2019-10-22 09:13:01 | Medical Products Industry Outlook: Prospects Seem Promising

2019-10-22 06:05:41 | Here's Why We Think Abbott Laboratories NYSE:ABT Is Well Worth Watching

2019-10-21 09:00:00 | The Australian Red Cross Blood Service Selects Abbott's Alinity s Solution for Blood and Plasma Screening

2019-10-18 11:13:03 | 3 Medical Product Stocks Likely to Beat This Earnings Season

2019-10-17 22:47:46 | Edited Transcript of ABT earnings conference call or presentation 16-Oct-19 1:00pm GMT

2019-10-16 16:19:35 | Investors Shrug Off Abbott's Mixed Report; Stock Bounces Off 200-Day Line

2019-10-16 16:11:01 | How Abbott Stock Reacted to the Company’s Q3 Results

2019-10-16 15:57:44 | T Rowe Price Equity Income Fund's Top 5 Buys in the 3rd Quarter

2019-10-16 15:49:53 | 5 Top Stock Trades for Thursday: ADBE, NFLX, ABT

2019-10-16 12:18:00 | [video]Stocks End Down as Trade War Fears, Weak Retail Sales Overshadow Strong Earnings

2019-10-16 11:42:48 | Abbott Labs, GM, MGM, Berkshire Hathaway, Intel: Stocks to Watch

2019-10-16 11:17:03 | Abbott ABT Meets Q3 Earnings Estimates, Lowers EPS Guidance

2019-10-16 10:29:25 | Abbott Labs, GM, MGM, Berkshire Hathaway, Intel: Companies to Watch

2019-10-16 07:47:03 | Abbott Laboratories Reports Mixed Q3 Earnings

2019-10-16 07:46:10 | Abbott revenue misses as heart devices eclipse diabetes gains

2019-10-16 07:44:00 | Abbott Labs stock falls after profit matches expectations, sales comes up a bit shy

2019-10-16 07:30:00 | Abbott Reports Third-Quarter 2019 Results

2019-10-16 07:00:00 | Abbott Laboratories to Host Earnings Call

2019-10-16 05:40:00 | Abbott Laboratories Narrows 2019 Profit Guidance After In-Line Q3 Earnings

2019-10-16 03:33:00 | Abbott Labs Earnings inline, Revenue Misses In Q3

2019-10-15 16:14:11 | Abbott Partnership Helps One Medtech Stock To Pop — As Another Dives

2019-10-15 13:25:00 | DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump

2019-10-15 12:43:31 | Options Red-Hot Ahead of Abbott Earnings

2019-10-15 10:37:02 | Can Structural Heart Strength Aid Abbott ABT Q3 Earnings?

2019-10-15 09:51:00 | Abbott Labs Rises 3%

2019-10-15 09:10:01 | Abbott Forms Alliance With Omada Health for Diabetes Care

2019-10-15 08:28:00 | Abbott Labs gets authorization for $3 billion in additional buybacks

2019-10-15 08:00:00 | Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management

2019-10-15 08:00:00 | Canadians Indicate Growing Concern About Road Safety at One-Year Anniversary of Recreational Cannabis Legalization, New Survey Finds

2019-10-15 06:25:00 | Abbott Laboratories Gets OK for Added $3 Billion of Stock Buybacks

2019-10-14 11:43:03 | Can Balanced Segmental Growth Aid Abbott ABT Q3 Earnings?

2019-10-14 10:03:36 | Exclusive: Abbott Labs sets timeline for $17M expansion in Tipp City

2019-10-14 09:00:00 | Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes